Radius Health (RDUS) Files $86.25M IPO
Tweet
Share
E-mailGet Alerts RDUS Hot Sheet
Join SI Premium – FREE
Radius Health, Inc. (Nasdaq: RDUS), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. Radius plans to list on the Nasdaq Global Market under the ticker, "RDUS."
The offering is being made through UBS Investment Bank, Leerink Swann, Cowen and Company, and Rodman & Renshaw, LLC.
Radius Health is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.
The offering is being made through UBS Investment Bank, Leerink Swann, Cowen and Company, and Rodman & Renshaw, LLC.
Radius Health is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.
Create E-mail Alert Related Categories
IPOsRelated Entities
UBS, Rodman & Renshaw, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
